Living donor liver transplantation for obese patients: Challenges and outcomes

Liver Transplantation

Volumn 20, Issue 3, 2014, Pages 311-322

  Gunay, Yusuf ^a   Guler, Necdet ^a   Dayangac, Murat ^a   Taskesen, Fatih ^a   Yaprak, Onur ^a   Emek, Ertan ^a   Akyildiz, Murat ^a   Altaca, Gulum ^a   Yuzer, Yildiray ^a   Tokat, Yaman ^a  

^a FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BILE LEAKAGE; BODY MASS; CHOLESTASIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DONOR SELECTION; END STAGE LIVER DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; OPERATIVE BLOOD LOSS; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SMALL FOR SIZE SYNDROME; SURVIVAL; TREATMENT OUTCOME; WOUND COMPLICATION;

ADOLESCENT; ADULT; BODY MASS INDEX; BODY WEIGHT; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84896706972     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23794     Document Type: Article

References (43)

1. Pelletier SJ, Schaubel DE, Wei G, Englesbe MJ, Punch JD, Wolfe RA, et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl 2007; 13: 1678-1683.
2. Sawyer RG, Pelletier SJ, Pruett TL,. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999; 13 (pt 2): 126-130.
3. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M,. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008; 8: 667-672.
4. Nair S, Verma S, Thuluvath PJ,. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002; 35: 105-109.
5. Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL Jr, Reyes JD, Perkins JD,. Liver transplantation at the extremes of the body mass index. Liver Transpl 2009; 15: 968-977.
6. Rustgi VK, Marino G, Rustgi S, Halpern MT, Johnson LB, Tolleris C, Taddei TH,. Impact of body mass index on graft failure and overall survival following liver transplant. Clin Transplant 2004; 18: 634-637.
7. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999; 67: 321-327.
8. Moon JI, Kwon CH, Joh JW, Jung GO, Choi GS, Park JB, et al. Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. Liver Transpl 2010; 16: 864-869.
9. Lee DS, Gil WH, Lee HH, Lee KW, Lee SK, Kim SJ, et al. Factors affecting graft survival after living donor liver transplantation. Transplant Proc 2004; 36: 2255-2256.
10. Lo CM, Fan ST, Chan JK, Wei W, Lo RJ, Lai CL,. Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation 1996; 62: 696-698.
11. Dahm F, Georgiev P, Clavien PA,. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5: 2605-2610.
12. Peng CJ, Yuan D, Li B, Wei YG, Yan LN, Wen TF, et al. Body mass index evaluating donor hepatic steatosis in living donor liver transplantation. Transplant Proc 2009; 41: 3556-3559.
13. Cucchetti A, Vivarelli M, Ravaioli M, Cescon M, Ercolani G, Piscaglia F, et al. Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? Clin Transplant 2009; 23: 519-524.
14. Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, et al. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl 2011; 17: 548-555.
15. Ratner LE, Sandoval PR,. When disaster strikes: death of a living organ donor. Am J Transplant 2010; 10: 2577-2581.
16. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Ninomiya M, Shiotani S, et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl 2003; 9: 581-586.
17. Soejima Y, Shirabe K, Taketomi A, Yoshizumi T, Uchiyama H, Ikegami T, et al. Left lobe living donor liver transplantation in adults. Am J Transplant 2012; 12: 1877-1885.
18. Dayangac M, Taner CB, Balci D, Memi I, Yaprak O, Akin B, et al. Use of middle hepatic vein in right lobe living donor liver transplantation. Transpl Int 2010; 23: 285-291.
19. Tucker ON, Heaton N,. The 'small for size' liver syndrome. Curr Opin Crit Care 2005; 11: 150-155.
20. Yagi S, Uemoto S,. Small-for-size syndrome in living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2012; 11: 570-576.
21. Perkins JD,. Saying "yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Liver Transpl 2006; 12: 1012-1013.
22. Yoo HY, Molmenti E, Thuluvath PJ,. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 2003; 9: 72-78.
23. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874-884.
24. de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol 2012; 27: 540-546.
25. Baccarani U, Isola M, Adani GL, Avellini C, Lorenzin D, Rossetto A, et al. Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant 2010; 24: 631-635.
26. Ureña MA, Ruiz-Delgado FC, González EM, Segurola CL, Romero CJ, García IG, et al. Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 1998; 30: 3288-3291.
27. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903-905.
28. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246-1251.
29. Seifalian AM, Chidambaram V, Rolles K, Davidson BR,. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998; 4: 71-77.
30. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, et al. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement. Transplantation 2009; 88: 575-581.
31. Ryan CK, Johnson LA, Germin BI, Marcos A,. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8: 1114-1122.
32. Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, et al.; for A2ALL Study Group. Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant 2012; 12: 1208-1217.
33. Iida T, Ogura Y, Oike F, Hatano E, Kaido T, Egawa H, et al. Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010; 89: 1276-1282.
34. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO,. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000; 135: 336-340.
35. Perito ER, Rhee S, Glidden D, Roberts JP, Rosenthal P,. Impact of the donor body mass index on the survival of pediatric liver transplant recipients and post-transplant obesity. Liver Transpl 2012; 18: 930-939.
36. Mazuelos F, Abril J, Zaragoza C, Rubio E, Moreno JM, Turriõn VS, Cuervas-Mons V,. Cardiovascular morbidity and obesity in adult liver transplant recipients. Transplant Proc 2003; 35: 1909-1910.
37. Hade AM, Shine AM, Kennedy NP, McCormick PA,. Both under-nutrition and obesity increase morbidity following liver transplantation. Ir Med J 2003; 96: 140-142.
38. Schaeffer DF, Yoshida EM, Buczkowski AK, Chung SW, Steinbrecher UP, Erb SE, Scudamore CH,. Surgical morbidity in severely obese liver transplant recipients-a single Canadian centre experience. Ann Hepatol 2009; 8: 38-40.
39. Hakeem AR, Cockbain AJ, Raza SS, Pollard SG, Toogood GJ, Attia MA, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl 2013; 19: 551-562.
40. LaMattina JC, Foley DP, Fernandez LA, Pirsch JD, Musat AI, D'Alessandro AM, Mezrich JD,. Complications associated with liver transplantation in the obese recipient. Clin Transplant 2012; 26: 910-918.
41. Padwal RS, Wang X, Sharma AM, Dyer D,. The impact of severe obesity on post-acute rehabilitation efficiency, length of stay, and hospital costs. J Obes 2012;2012: 972365.
42. Hillingsø JG, Wettergren A, Hyoudo M, Kirkegaard P,. Obesity increases mortality in liver transplantation-the Danish experience. Transpl Int 2005; 18: 1231-1235.
43. Perez-Protto SE, Quintini C, Reynolds LF, You J, Cywinski JB, Sessler DI, Miller C,. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl 2013; 19: 907-915.